Latest publications

Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study. Oosterhaven JAF, Voorberg AN, Romeijn GLE, De Bruin-Weller MS, Schuttelaar MLA et al. J. Dermatol. 2019 Jun 12

Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2. Cork MJ, Eckert L, Simpson EL, Armstrong A, Barbarot S, Puig L et al. J Dermatolog Treat 2019 Jun 09:1-9

Probability of sentinel lymph node positivity in melanoma. El Sharouni MA, Witkamp AJ, Sigurdsson V, Van Diest PJ et al. Eur. J. Cancer 2019 Jun 01; 116:10-12

Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next? Van der Schaft J, Thijs JL, De Bruin-Weller MS, Balak DMW et al. Curr Opin Allergy Clin Immunol 2019 May 27

Management der Dupilumab-assoziierten Konjunktivitis beim atopischen Ekzem. Aszodi N, Thurau S, Seegräber M, De Bruin-Weller M, Wollenberg A et al. J Dtsch Dermatol Ges 2019 05; 17(5):488-492

Dupilumab versus Cyclosporine for Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index. Ariëns LFM, Gadkari A, Van Os-Medendorp H, Ayyagari R, Terasawa E, Kuznik A et al. Acta Derm. Venereol. 2019 05 17

Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment. Ariëns LFM, Van Nimwegen KJM, Shams M, De Bruin DT, Van der Schaft J, Van Os-Medendorp H et al. Acta Derm. Venereol. 2019 05 10

Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis. Eichenfield LF, Bieber T, Beck LA, Simpson EL, Thaçi D, De Bruin-Weller M et al. Am J Clin Dermatol 2019 Jun; 20(3):443-456

Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy - international eczema council survey and opinion. Thyssen JP, De Bruin-Weller MS, Paller AS, Leshem YA, Vestergaard C, Deleuran M et al. J Eur Acad Dermatol Venereol 2019 May 06

Perceived triggers of asthma impair quality of life in children with asthma. Kansen HM, Le TM, Meijer Y, Uiterwaal CSPM, Knulst AC, Van der Ent CK et al. Clin. Exp. Allergy 2019 Apr 30

Biomarkers detected in dried blood spots from atopic dermatitis patients strongly correlate with disease severity. Thijs JL, Fiechter R, Giovannone B, De Bruin-Weller MS, Knol EF, Bruijnzeel-Koomen CAFM et al. Allergy 2019 Apr 23

[Ocular symptoms associated with dupilumab in atopic dermatitis]. Voorberg AN, Oosterhaven JAF, Wijdh RHJ, De Bruin-Weller MS, Schuttelaar MLA et al. Ned Tijdschr Geneeskd 2019 Mar 21; 163

Food Allergy in Adults: Substantial Variation in Prevalence and Causative Foods Across Europe. Lyons SA, Burney PGJ, Ballmer-Weber BK, Fernandez-Rivas M, Barreales L, Clausen M et al. J Allergy Clin Immunol Pract 2019 Mar 19

Management of dupilumab-associated conjunctivitis in atopic dermatitis. Aszodi N, Thurau S, Seegräber M, De Bruin-Weller M, Wollenberg A et al. J Dtsch Dermatol Ges 2019 May; 17(5):488-491

Conjunctivitis in dupilumab clinical trials. Akinlade B, Guttman-Yassky E, De Bruin-Weller M, Simpson EL, Blauvelt A, Cork MJ et al. Br. J. Dermatol. 2019 Mar 09